Company Overview and News

1
Troubled Napier railway land earmarked for new shopping centre

2018-06-25 nzherald.co.nz
Former Napier railway land used as free parking while caught in a Treaty of Waitangi settlement tangle for more than 20 years is earmarked for a new shopping centre.
BGR

2
Govt vows to crack down on exploitation of migrant workers

2018-06-08 nzherald.co.nz
Businesses are not doing enough to look after their staff and meet compulsory employment standards, says Workplace Relations and Safety Minister Iain Lees-Galloway.
BGR JBHHY JBH

16
Shares rise, led by A2 and Synlait

2018-05-17 nzherald.co.nz
New Zealand shares rose, led by A2 Milk Co and Synlait Milk while Pushpay fell after annual earnings met its guidance, disappointing some upbeat investors.
BGR WBC SPKKY NZTCY SPK NZTCF WEBNF WBK SKT SYKWF WBC PPSHY VTHPF SKKTY SML

1
Cotton On Group to review its paid work practices, as tide of complaints swells to 1,500

2018-05-17 nzherald.co.nz
Retail company Cotton On Group is the latest company to launch a full enquiry into the workplace practices of its staff following the Smiths City employment case.
BGR

1
Briscoe to reimburse staff for unpaid end-of-day cash-up

2018-05-16 nzherald.co.nz
Briscoe Group will reimburse staff who cashed up at the end of the day but didn't get paid for the time, something managing director Rod Duke says is company policy.
BGR

1
Paid work overhaul for retail, sales and hospitality staff looming: Employment lawyer

2018-05-16 nzherald.co.nz
The retail and hospitality sectors need to prepare for changes coming as to what is deemed as paid and unpaid work for staff, says an employment lawyer.
BGR

11
A2 to join MSCI main stock index as Mercury drops off

2018-05-14 nzherald.co.nz
A review of global stock indices by MSCI will, as expected, add A2 Milk to the international investment advisor's main global index, with Mercury New Zealand to be removed.
BGR FBU MHI FBU THL FCREY MXRHY FRCEF MXRHF SML

11
Fletcher gains as stock stays in MSCI main index

2018-05-14 nzherald.co.nz
A review of global stock indices by MSCI has seen Fletcher Building shares gain after news the stock will remain on the international investment adviser's main global index, with A2 Milk rising on its planned entry and Mercury New Zealand dipping due to its planned removal.
BGR FBU MHI FBU THL FCREY MXRHY FRCEF MXRHF SML

9
Port of Tauranga leads stockmarket higher

2018-05-07 nzherald.co.nz
New Zealand shares gained, led higher by Gentrack Group and Port of Tauranga, with Westpac Banking Corp gaining on its first-half result.
KTHDY BGR WBC SKC WBC GTK WEBNF WBK KMD KMD

8
MARKET WRAP: NZ shares rise, Xero flies

2018-05-07 nbr.co.nz
Harbour Asset Management analyst Shane Solly says Westpac is still under pressure following the Royal Commission’s findings.
ZNZ BGR RHCGF RYHTY ZNRGF RYM ZEL

1
Briscoe first-quarter sales rise 3.6 pct as Rebel Sport kicks off strong start to year

2018-05-07 nzherald.co.nz
Briscoe Group's first-quarter sales rose 3.6 percent as the retailer's Rebel Sport chain was a swift starter in the year, outperforming the flagship homeware division.
BGR

22
NZ shares gain; Trade Me rises

2018-04-18 nzherald.co.nz
New Zealand shares gained in light trading as Fletcher Building's discounted rights issue and upcoming MSCI New Zealand index review weighed on investors' minds. Trade Me and Metlifecare increased while Comvita dropped.
KTHDY BGR AIA FBU FCREY SPKKY NZTCY SPK NZTCF ACKDF FRCEF AUKNY KMD SKT SYKWF AIA PPSHY FBU SKKTY KMD MEZ SML

2
The Interview: Kathmandu CEO Xavier Simonet finds a home in the outdoors

2018-04-13 nzherald.co.nz
Kathmandu's chief executive Xavier Simonet sees the public company as a New Zealand brand "born in the mountains".
BGR

1
'Have we just become slobs?': Video captures mess at Rebel Sport Botany during Easter sales

2018-04-03 nzherald.co.nz
A former journalist has shared a shocking video of the aftermath of Easter retail sales at a Rebel Sport store in Botany, Auckland.
BGR

1
'I'm old-fashioned': Myer's Hounsell goes shopping for people like him

2018-03-21 theage.com.au
So Myer’s newly minted executive chairman Garry Hounsell is following the very traditional path as he cleans up the mess created by the CEO he just fired: Richard Umbers.
BGR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NZX:BGR / Briscoe Group on message board site Silicon Investor.

Berger Holdings BGRH Ask BGR
BTD Club, your hosts, BGR and Paperchase